Thalys Medical Technology Group Corporation (SHA:603716)

SHA:603716 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,615	1,350	2,126	2,115	2,800	3,265
Market Cap Growth	258.71%	-36.50%	0.51%	-24.45%	-14.23%	-5.78%
Enterprise Value	5,021	2,305	3,163	3,337	3,959	4,036
Last Close Price	22.38	7.22	11.09	11.04	14.39	16.47
PE Ratio	-	-	-	-	-	56.72
Forward PE	-	35.82	35.82	35.82	35.82	35.82
PS Ratio	3.70	0.75	1.06	0.92	1.08	1.54
PB Ratio	4.38	1.40	1.62	1.41	1.61	1.81
P/TBV Ratio	4.54	1.57	2.00	1.72	2.04	2.24
P/FCF Ratio	77.22	17.68	25.00	-	-	-
P/OCF Ratio	61.95	13.56	16.89	75.23	-	328.31
EV/Sales Ratio	4.02	1.27	1.58	1.45	1.52	1.90
EV/EBITDA Ratio	-	48.74	94.19	73.79	23.73	16.09
EV/EBIT Ratio	-	179.00	-	-	41.75	23.15
EV/FCF Ratio	84.01	30.18	37.19	-	-	-
Debt / Equity Ratio	0.56	0.96	0.80	0.94	0.92	0.78
Debt / EBITDA Ratio	-	14.48	18.82	20.41	8.37	5.57
Debt / FCF Ratio	9.78	12.11	12.34	-	-	-
Asset Turnover	0.48	0.59	0.55	0.56	0.63	0.62
Inventory Turnover	3.79	4.44	4.24	4.21	4.75	4.36
Quick Ratio	1.08	1.23	1.42	1.32	1.53	1.75
Current Ratio	1.38	1.52	1.72	1.61	1.87	2.11
Return on Equity (ROE)	-21.75%	-16.99%	-11.15%	-11.74%	-2.17%	4.79%
Return on Assets (ROA)	-2.02%	0.26%	-0.32%	-0.24%	1.44%	3.15%
Return on Invested Capital (ROIC)	-5.52%	0.68%	-0.82%	-0.58%	3.51%	5.87%
Return on Capital Employed (ROCE)	-7.80%	0.90%	-1.00%	-0.70%	3.70%	6.90%
Earnings Yield	-5.21%	-15.50%	-7.46%	-7.27%	-1.77%	1.76%
FCF Yield	1.29%	5.66%	4.00%	-1.25%	-6.92%	-3.61%
Payout Ratio	-	-	-	-	-	103.03%
Buyback Yield / Dilution	4.89%	0.73%	0.62%	1.73%	0.23%	-0.66%
Total Shareholder Return	4.89%	0.73%	0.62%	1.73%	0.23%	-0.66%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.